Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EOG RESOURCES INC Director's Dealing 2022

Nov 9, 2022

29963_dirs_2022-11-09_25a4eccb-8bbe-49ff-ace8-ce05994b4a59.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EOG RESOURCES INC (EOG)
CIK: 0000821189
Period of Report: 2022-11-07

Reporting Person: Donaldson Michael P (EVP, Gen. Counsel & Corp Sec)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-11-07 Common Stock M 12056 $127.00 Acquired 125798.635 Direct
2022-11-07 Common Stock D 10490 $145.97 Disposed 115308.635 Direct
2022-11-07 Common Stock F 616 $145.97 Disposed 114692.635 Direct
2022-11-07 Common Stock M 4160 $75.09 Acquired 118852.635 Direct
2022-11-07 Common Stock D 2140 $145.97 Disposed 116712.635 Direct
2022-11-07 Common Stock F 795 $145.97 Disposed 115917.635 Direct
2022-11-07 Common Stock M 4074 $37.44 Acquired 119991.635 Direct
2022-11-07 Common Stock D 1045 $145.97 Disposed 118946.635 Direct
2022-11-07 Common Stock F 1192 $145.97 Disposed 117754.635 Direct
2022-11-07 Common Stock M 4074 $81.81 Acquired 121828.635 Direct
2022-11-07 Common Stock D 2284 $145.97 Disposed 119544.635 Direct
2022-11-07 Common Stock F 704 $145.97 Disposed 118840.635 Direct
2022-11-08 Common Stock S 4465 $148.00 Disposed 114375.635 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-11-07 Stock Appreciation Rights $127.00 M 12056 Disposed 2025-09-27 Common Stock (12056) Direct
2022-11-07 Stock Appreciation Rights $75.09 M 4160 Disposed 2026-09-26 Common Stock (4160) Direct
2022-11-07 Stock Appreciation Rights $37.44 M 4074 Disposed 2027-09-28 Common Stock (4074) Direct
2022-11-07 Stock Appreciation Rights $81.81 M 4074 Disposed 2028-09-27 Common Stock (4074) Direct

Footnotes

F1: The SARs granted became exercisable in increments of 33%, 33% and 34% on each of the first three anniversaries, respectively, of the September 27, 2018 date of grant. The SARs granted became fully exercisable on September 27, 2021. This exercise did not involve any open-market sale of the Issuer's Common Stock.

F2: The SARs granted became exercisable in increments of 33%, 33% and 34% on each of the first three anniversaries, respectively, of the September 26, 2019 date of grant. The SARs granted became fully exercisable on September 26, 2022. This exercise did not involve any open-market sale of the Issuer's Common Stock.

F3: The SARs granted become exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 28, 2020 date of grant. The SARs granted will become fully exercisable on September 28, 2023. This exercise did not involve any open-market sale of the Issuer's Common Stock.

F4: The SARs granted become exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 27, 2021 date of grant. The SARs granted will become fully exercisable on September 27, 2024. This exercise did not involve any open-market sale of the Issuer's Common Stock.